The WHO pointed out that the improper use of the drug could cause adverse effects.
The novel coronavirus or COVID-19, which is believed to be originated from the city of Wuhan in China, has now infected over 57 million people worldwide.
While over 300 vaccines are currently being developed to combat the virus, the Sputnik V vaccine developed by Russia, as well as vaccines developed by Moderna, Pfizer, Oxford University and China has thus far been effective during trials.
The drug remdesivir has been utilized previously to treat patients infected with Ebola and has been using to treat COVID infected patients as well with reports that it boosts the immune system and respiratory capacity of patients with the infection.
However, a long-term study by the WHO found that the use of remdesivir did not improve a person's immunity or respiratory function. They further warn that overdose of Remediesivir can sometimes cause serious side effects.
Since the vaccine must be stored at a temperature of minus 80 degrees Celsius, many cargo companies have taken steps to transport the vaccine globally using dry ice. However, the global vaccine shipment has been hampered by the fact that dry ice, which has a temperature of minus 78 degrees Celsius, has to be repackaged every five days.
Most of the drugs and antibiotics used in the world today are stored at temperatures below minus 10 degrees Celsius.
Meanwhile, the German company ‘Binder’ has developed a new refrigerator that can maintain a temperature of minus 90 degrees.